- Home
- DYAI vs TOI Comparison
DYAI vs TOI Comparison
Compare DYAI & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYAI
- TOI
- Stock Information
- Founded
- DYAI 1979
- TOI 2007
- Country
- DYAI United States
- TOI United States
- Employees
- DYAI N/A
- TOI N/A
- Industry
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- TOI Medical/Nursing Services
- Sector
- DYAI Health Care
- TOI Health Care
- Exchange
- DYAI Nasdaq
- TOI Nasdaq
- Market Cap
- DYAI 54.4M
- TOI 49.1M
- IPO Year
- DYAI 2004
- TOI N/A
- Fundamental
- Price
- DYAI $1.38
- TOI $1.26
- Analyst Decision
- DYAI Strong Buy
- TOI
- Analyst Count
- DYAI 1
- TOI 0
- Target Price
- DYAI $6.00
- TOI N/A
- AVG Volume (30 Days)
- DYAI 59.9K
- TOI 518.7K
- Earning Date
- DYAI 03-26-2025
- TOI 05-13-2025
- Dividend Yield
- DYAI N/A
- TOI N/A
- EPS Growth
- DYAI N/A
- TOI N/A
- EPS
- DYAI N/A
- TOI N/A
- Revenue
- DYAI $3,495,389.00
- TOI $393,412,000.00
- Revenue This Year
- DYAI $51.30
- TOI $23.95
- Revenue Next Year
- DYAI $73.26
- TOI N/A
- P/E Ratio
- DYAI N/A
- TOI N/A
- Revenue Growth
- DYAI 20.58
- TOI 21.33
- 52 Week Low
- DYAI $0.93
- TOI $0.13
- 52 Week High
- DYAI $2.67
- TOI $1.63
- Technical
- Relative Strength Index (RSI)
- DYAI 46.47
- TOI 69.32
- Support Level
- DYAI $1.29
- TOI $0.97
- Resistance Level
- DYAI $1.45
- TOI $1.34
- Average True Range (ATR)
- DYAI 0.10
- TOI 0.18
- MACD
- DYAI 0.00
- TOI 0.04
- Stochastic Oscillator
- DYAI 41.38
- TOI 78.85
About DYAI Dyadic International Inc.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.